Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lotus Eye Hospital & InstituteBOM:532998 -1.71%67 PB Ratio is 4.07 as of Aug. 13, 2026, which is 130% above its 10-year median of 1.77. GuruFocus rates BOM:532998 with a GF Score™ of 67/100 and a GF Value™ of ₹92.54 (Modestly Overvalued). Among 610 Healthcare Providers & Services companies, Lotus Eye Hospital & Institute ranks worse than 74.43% on this metric.
The historical rank and industry rank for Lotus Eye Hospital & Institute's PB Ratio or its related term are showing as below:
BOM:532998'
s PB Ratio Range Over the Past 10 Years
Min: 0.75 Med: 1.77 Max: 4.66
Current: 4.07
During the past 13 years, Lotus Eye Hospital & Institute's highest PB Ratio was 4.66. The lowest was 0.75. And the median was 1.77.
BOM:532998's PB Ratio is ranked worse than 74.43% of 610
companies
in the Healthcare Providers & Services industry
Industry Median: 2.06
vs BOM:532998: 4.07
During the past 12 months, Lotus Eye Hospital & Institute's average Book Value Per Share Growth Rate was 0.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 1.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 2.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 2.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Lotus Eye Hospital & Institute was 4.10% per year. The lowest was -1.20% per year. And the median was 0.80% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Lotus Eye Hospital & Institute PB Ratio Related Terms
Lotus Eye Hospital & Institute PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lotus Eye Hospital & Institute PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's PB Ratio distribution charts can be found below:
* The bar in red indicates where Lotus Eye Hospital & Institute's PB Ratio falls into.
Lotus Eye Hospital & Institute PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Lotus Eye Hospital & Institute (BOM:532998) has a PB Ratio of 4.07 as of Aug. 13, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Lotus Eye Hospital & Institute and its competitors. This is 130% above median its historical median of 1.77. Over the past decade, Lotus Eye Hospital & Institute's PB Ratio has ranged from 0.75 to 4.66. According to the industry distribution chart, Lotus Eye Hospital & Institute ranks #454 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 74.4%.
Is Lotus Eye Hospital & Institute's PB Ratio too high?
Lotus Eye Hospital & Institute's current PB Ratio of 4.07 is 130% above median its 10-year median of 1.77. Over the past 10 years, this metric has ranged from a low of 0.75 to a high of 4.66. The Healthcare Providers & Services industry median PB Ratio is 2.06. Lotus Eye Hospital & Institute's value of 4.07 is 97.6% above this industry median. Based on the distribution chart, Lotus Eye Hospital & Institute ranks #454 out of 610 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Lotus Eye Hospital & Institute ranks #454 out of 610 companies for PB Ratio. This places Lotus Eye Hospital & Institute in the lower half of its industry. The industry median PB Ratio is 2.06. Lotus Eye Hospital & Institute's value of 4.07 is 97.6% above this benchmark. Historically, Lotus Eye Hospital & Institute's own PB Ratio has ranged from 0.75 to 4.66 over the past decade. While the company's 10-year median is 1.77 vs. the industry median of 2.06, Lotus Eye Hospital & Institute has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.06, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lotus Eye Hospital & Institute's current PB Ratio of 4.07 is 97.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Lotus Eye Hospital & Institute and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Eye Hospital & Institute's current PB Ratio is 4.07, which is 130% above median its own 10-year median of 1.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹92.54, compared to a current price of ₹117.75 — trading 27.2% above its estimated fair value. The current PB Ratio is 4.07, which is 130% above median its 10-year median of 1.77 and 97.6% above the Healthcare Providers & Services industry median of 2.06. Lotus Eye Hospital & Institute's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current PB Ratio is 4.07 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued.
The current stock price of ₹117.75 is trading 27.2% above its estimated GF Value™ of ₹92.54.
GuruFocus considers Lotus Eye Hospital & Institute to be Modestly Overvalued.
Key valuation signals for BOM:532998:
PB Ratio: 4.07 (130% above median its 10-year median of 1.77)
GF Value™: ₹92.54 vs. price of ₹117.75 (27.2% above fair value)
Industry Position: 97.6% above the Healthcare Providers & Services median (#454 of 610)
No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
67GF Score
Get the complete analysis for BOM:532998
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532998 has been successfully added to your 
